KKRC
ZBH icon

Kohlberg Kravis Roberts & Co’s Zimmer Biomet ZBH Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,877,765
Closed -$453M – 61
2016
Q2 		$453M Sell
3,877,765
-3,877,764
-50% -$439M 4.77% 5
2016
Q1 		$803M Hold
7,755,529
– – 7.95% 4
2015
Q4 		$772M Hold
7,755,529
– – 7.52% 4
2015
Q3 		$707M Hold
7,755,529
– – 7.52% 4
2015
Q2 		$822M Buy
+7,755,529
New +$858M 7.43% 5

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's ZBH Position: Q3 2016 in Review

Kohlberg Kravis Roberts & Co sold out of Zimmer Biomet (ZBH) in Q3 2016, closing a stake of 3,877,765 shares — an estimated $453M sold.

Kohlberg Kravis Roberts & Co first reported a position in ZBH in Q2 2015 and held it in 5 quarters. The position peaked at $822M in Q2 2015. 808 funds tracked by Wall St. Rank hold ZBH as of Q3 2016.

  • Kohlberg Kravis Roberts & Co reported no remaining Zimmer Biomet position as of Q3 2016 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 3,877,765 Zimmer Biomet shares in Q3 2016, an estimated $453M.
  • Kohlberg Kravis Roberts & Co first reported a position in Zimmer Biomet in Q2 2015 and held it in 5 quarters.
  • Kohlberg Kravis Roberts & Co's Zimmer Biomet position peaked at $822M in Q2 2015.
  • 808 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2016.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2016, filed 14 Nov 2016.